Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novavax Inc (NQ: NVAX ) 14.96 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Novavax Inc < Previous 1 2 ... 5 6 7 8 9 10 11 12 13 ... 58 59 Next > Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On? October 03, 2023 Novavax Inc (NASDAQ: NVAX) shares are surging Tuesday afternoon after the U.S. Via Benzinga Exposures COVID-19 Product Safety Why Pfizer and BioNTech Stocks Zoomed Higher Today September 29, 2023 The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle. Via The Motley Fool Exposures COVID-19 NVAX, AI, CVNA: The 3 Most Shorted Stocks This Month September 28, 2023 With the market suffering losses due to broader headwinds, hedge funds have targeted the most shorted stocks for cynical profits. Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done September 26, 2023 Investors should do their due diligence before investing in these three risky, unreliable and unprofitable biotech stocks. Via InvestorPlace Does This Message From Moderna Mean Bad News for Novavax? September 21, 2023 So far, Novavax has lagged behind Moderna when it comes to bringing a vaccine to market. Via The Motley Fool Up 20% in 1 Month, Is This Stock a Buy? September 13, 2023 As Covid cases rise, Novavax is getting more attention again. But will the momentum last? Via The Motley Fool Exposures COVID-19 You Can Pick Up These High-Risk, High-Reward Stocks for Less Than $10 September 19, 2023 These stocks look cheap right now -- if the companies can meet their goals. Via The Motley Fool Is This 250-Year-Old Japanese Big Pharma Giant Selling For Half Price Right Now? September 18, 2023 When it comes to Big Pharma, Japan’s Takeda Pharmaceutical Co Ltd (NYSE: TAK) is a conservative play that could prove to be a big winner given its cheap valuation and suite of new drugs that portend to... Via Benzinga More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone September 15, 2023 New COVID-19 boosters have been approved by the U.S. FDA in the fight against new variants. A new survey showed how likely people are to get new boosters and if they will have their children get... Via Benzinga Exposures COVID-19 Product Safety Why COVID Vaccine Demand Might Not Be That Strong September 14, 2023 COVID hospitalizations are rising, but they're nowhere near the levels they were at a year or two ago. Via The Motley Fool Exposures COVID-19 Novavax Is a Step Behind, Again. Should You Be Worried? September 14, 2023 The FDA still is reviewing Novavax's updated vaccine candidate. Via The Motley Fool Exposures Product Safety DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories September 12, 2023 Benzinga Via Benzinga Tesla, Oracle, Novavax, DraftKings, Pfizer: Why These Five Stocks Are Tending Today September 11, 2023 U.S. stocks showcased a positive momentum as the trading day approached its end. The Nasdaq Composite exhibited a notable rise, gaining more than 1% on Monday. Via Benzinga Topics Stocks Exposures US Equities Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits September 11, 2023 The U.S. Via Benzinga Exposures COVID-19 Product Safety Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters September 11, 2023 Novavax says it's working with the FDA to answer final requests as part of the agency's review. Via Investor's Business Daily Exposures COVID-19 Product Safety 7 Biotech Stocks to Sell in September Before They Crash & Burn September 06, 2023 These are just a few of the top biotech stocks to sell today - especially with each of the firms dealing with legitimate issues. Via InvestorPlace Non-Disappearing COVID Creates Another Chapter For The Pharmaceutical Industry September 06, 2023 On Tuesday, UK regulators joined their US and European peers in approving an updated COVID-19 vaccine by Pfizer Inc (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) that targets only the... Via Benzinga Exposures COVID-19 Here's How Moderna's Updated Covid Shot Stacks Up Against Highly Mutated 'Pirola' Variant September 06, 2023 Pirola has about 30 mutations compared with previous omicron versions of the virus. Via Investor's Business Daily Exposures COVID-19 This Down-on-Its-Luck Biotech Could Surge 150%, Wall Street Says. Should You Buy the Stock? September 06, 2023 Today, Novavax is getting ready to compete in the fall vaccine market -- one that's in transition. Via The Motley Fool Novavax, Zscaler, Digital Brands Group, Asana, Tesla: Why These 5 Stocks Are Drawing Investor Attention Today September 05, 2023 Via Benzinga Why Novavax Stock Rocketed 10% Higher Today September 05, 2023 The COVID vaccine maker benefits on a day when worries about a surge intensify with a new case at the White House. Via The Motley Fool Exposures COVID-19 Why Novavax Stock Traded Higher Today September 05, 2023 Novavax, Inc. (NASDAQ: NVAX) shares trader higher Tuesday amid rising COVID cases in the US, which has lifted vaccine stocks in recent weeks. Via Benzinga Exposures COVID-19 Coronavirus Cases Are on the Rise -- Should You Buy Vaccine Stocks? September 05, 2023 Investors have worried about vaccine revenue in a post-pandemic world. Via The Motley Fool Exposures COVID-19 2 Stocks That Doubled EPS Estimates and Flashing Buy Signals September 01, 2023 The second quarter of the 2023 earnings season has drawn to a close. There were many surprises in every sector. However, there were some standout surprises with Via MarketBeat Exposures COVID-19 7 Undervalued Stocks Due for a Massive Short Squeeze September 01, 2023 These are the undervalued short squeeze candidates and these stocks represent fundamentally strong growth companies Via InvestorPlace 3 Biotech Stocks Due for a Massive Short Squeeze August 31, 2023 These are the biotech short squeeze candidates to buy and hold for a massive rally of up to 100% in the coming quarters. Via InvestorPlace Should You Buy Novavax's Stock Before the FDA Approves Its New COVID Shot? August 31, 2023 The vaccine's approval could come within weeks. Via The Motley Fool Exposures COVID-19 Product Safety 3 of Wall Street’s Most Shorted Stocks Due for a Massive Short Squeeze August 30, 2023 These are the most shorted stocks trading in the U.S. stock market, and any good news could put their short sellers into a serious bind. Via InvestorPlace Why Novavax Stock Was So Healthy on Monday August 28, 2023 As the coronavirus threat rises, so too does the vaccine maker's value to investors. Via The Motley Fool Exposures COVID-19 Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session August 28, 2023 Gainers Mobile Infrastructure Corporation (NASDAQ: BEEP) shares jumped 98.7% to $12.02. Via Benzinga < Previous 1 2 ... 5 6 7 8 9 10 11 12 13 ... 58 59 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.